SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,710,491 | -13.8% | 47,212 | -15.1% | 0.04% | +17.6% |
Q4 2022 | $1,983,537 | -2.1% | 55,608 | -7.1% | 0.03% | 0.0% |
Q3 2022 | $2,026,000 | +248.7% | 59,838 | +232.7% | 0.03% | +209.1% |
Q1 2022 | $581,000 | +13.7% | 17,986 | +8.4% | 0.01% | +22.2% |
Q2 2021 | $511,000 | -31.4% | 16,588 | -41.7% | 0.01% | -30.8% |
Q1 2021 | $745,000 | +127.1% | 28,454 | +118.1% | 0.01% | +116.7% |
Q4 2020 | $328,000 | -4.7% | 13,045 | -20.9% | 0.01% | -40.0% |
Q3 2020 | $344,000 | -6.5% | 16,500 | +6.5% | 0.01% | -44.4% |
Q2 2020 | $368,000 | – | 15,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |